Thermo Fisher Plans Public Offering of $2.2B to Fund Life Tech Buy; Expects Another FTC Request | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific announced after the close of the market on Wednesday a public offering of $2.2 billion of its common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.